Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market
Holding AMLX?
Track your performance easily

Amylyx Pharmaceuticals Inc (AMLX) Financial Statements

510 Followers

Amylyx Pharmaceuticals Inc Financial Overview

Amylyx Pharmaceuticals Inc's market cap is currently ―. The company's EPS TTM is $-3.818; its P/E ratio is -1.75; Amylyx Pharmaceuticals Inc is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 416.00K$ -1.02M$ 88.64M$ 108.45M$ 102.69M
Gross Profit$ 416.00K$ -1.03M$ -27.76M$ 99.09M$ 97.47M
EBIT$ -72.70M$ -72.70M$ -122.13M-$ 18.72M
EBITDA$ -72.48M$ -69.91M$ -121.81M-$ 19.02M
Net Income Common Stockholders$ -72.70M$ -65.29M$ -118.79M$ 4.70M$ 20.89M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 234.40M$ 309.81M$ 373.29M$ 371.36M$ 355.05M
Total Assets$ 250.71M$ 332.16M$ 417.46M$ 517.45M$ 466.58M
Total Debt$ 2.57M$ 3.14M$ 3.69M$ 4.24M$ 4.77M
Net Debt$ -231.83M$ -306.67M$ -369.60M$ -367.13M$ -350.28M
Total Liabilities$ 54.51M$ 70.85M$ 93.02M$ 84.02M$ 48.18M
Stockholders Equity$ 196.20M$ 261.31M$ 324.44M$ 433.43M$ 418.40M
Cash Flow-
Free Cash Flow$ -77.75M$ -66.67M$ -556.00K-$ -5.53M
Operating Cash Flow$ -41.57M$ -66.58M$ -489.00K$ 13.55M$ -5.17M
Investing Cash Flow$ 38.82M$ -28.96M$ 819.00K$ 20.93M$ -108.09M
Financing Cash Flow$ 80.00K$ 27.00K$ 131.00K$ 230.00K$ 889.00K
Currency in USD

Amylyx Pharmaceuticals Inc Earnings and Revenue History

Amylyx Pharmaceuticals Inc Debt to Assets

Amylyx Pharmaceuticals Inc Cash Flow

Amylyx Pharmaceuticals Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis